Benefits and Risks of Long-term Amiodarone Therapy for Persistent Atrial Fibrillation: A Meta-analysis

Doyle, James F.; Ho, Kwok M.
March 2009
Mayo Clinic Proceedings;Mar2009, Vol. 84 Issue 3, p234
Academic Journal
OBJECTIVE: To assess whether amlodarone, as part of a strategy to achieve sinus rhythm, is safe and effective compared with a placebo or rate control drug in patients with persistent atrial fibrillation (AF) of more than 30 days' duration. METHODS: Randomized controlled trials comparing amlodarone with a placebo or rate control drug were Identified through the EMBASE (January 1, 1988, to October 18, 2008), MEDLINE (January 1, 1966, to October 18, 2008), and Cochrane Controlled Trials Register (second Issue 2008) databases with no language restrictions. RESULTS: Twelve randomized controlled trials that Involved a total of 5060 patients with persistent AF were considered. Amiodarone was more effective than a placebo or rate control drug In achieving sinus rhythm (21.3 vs 9.2 per 100 patient-years In sinus rhythm; relative risk [RR], 3.2; 95% confidence Interval [Cl], 1.9- 5.5), and Its use was not associated with an Increased risk of long-term mortality (4.7 vs 3.9 per 100 patient-years; RR, 0.95; 95% Cl, 0.8-1.1; P=.51; I²=0%). Cessation of amiodarone therapy because of Intolerable adverse effects was more common compared with a placebo or rate control drug (10.7 vs 1.9 per 100 patient-years; RR, 3.0; 95% Cl, 1.4-6.2; P<.001; P=70%), but amiodarone was not associated with an increased incidence of hospitalizations (RR, 1.1; 95% CI, 0.6-2.1; P=.77; I²=90%). CONCLUSION: Amiodarone, as part of a strategy to achieve and maintain sinus rhythm, appears to be safe and effective In patients with persistent AF. However, some patients may not tolerate the adverse effects of this agent.


Related Articles

  • The rate vs rhythm debate.  // Primary Care Reports;Apr2009 Pharmacology Watch, p1 

    The article discusses a study which showed that a dronedarone, a derivative of amiodarone, decreases the hospitalization rate and death rate in atrial fibrillation. Patients with atrial fibrillation and one additional risk factor for death were randomly given dronedarone or placebo. It was found...

  • Conversion of Recent-Onset Atrial Fibrillation: Which Drug is the Best? Conde, Diego; Elissamburu, Pablo; Lalor, Nicolas; Rodriguez, Leandro; Aragon, Martin; Costabel, Juan Pablo; Lambardi, Florencia; Trivi, Marcelo // JAFIB: Journal of Atrial Fibrillation;Aug/Sep2013, Vol. 6 Issue 2, p7 

    Introduction: Vernakalant is a new, safe and effective drug used intravenously. It has proven to be more rapid in converting recent onset atrial fibrillation (AF) to sinus rhythm compared to placebo, amiodarone, propafenone and flecainide in clinical studies with few patients. At present no...

  • Is a single oral dose of amiodarone safe and effective in converting new-onset atrial fibrillation (AF) to sinus rhythm? DeSimone, Kristin Lengle // Journal of Family Practice;Jun2000, Vol. 49 Issue 6, p493 

    The article discusses research being done on the effectiveness of amiodarone in the treatment of atrial fibrillation (AF), with reference to a study by K. Peuhkurinen, M. Niemela, A. Ylitalo, et al., which appeared in the 2000 issue of the "American Journal of Cardiology." Patients included in...

  • Post-ATHENA and beyond. Naccarelli, Gerald V. // Journal of Interventional Cardiac Electrophysiology;Jun2011, Vol. 31 Issue 1, p55 

    Dronedarone, an amiodarone analog, was developed to be a safer alternative to amiodarone. Dronedarone is useful in suppressing atrial fibrillation/flutter and controlling the ventricular response. Dronedarone reduced cardiovascular hospitalization in the ATHENA trial (A placebo-controlled,...

  • The rate vs rhythm debate. Elliott, William T. // Travel Medicine Advisor;Apr2009 Pharmacology Watch, p1 

    The article discusses research on the effects of the drug dronedarone, a derivative of amiodarone, in patients with atrial fibrillation (AF). It references a study published in a 2009 issue of the "New England Journal of Medicine." Clinical data showed that drug lowered hospitalization and death...

  • Aminodarone for Cardioversion on Recent-Onset Atrial Fibrillation. Miller, Karl E. // American Family Physician;7/15/2003, Vol. 68 Issue 2, p369 

    Discusses the study 'Amiodarone Versus Placebo and Class Ic Drugs for Cardioversion of Recent-Onset Atrial Fibrillation: A Meta-Analysis,' by P. Chevalier et al., from the January 15, 2003 issue of the 'Journal of the American College of Cardiology.'

  • Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial. Galperin, Jorge; Elizari, Marcelo V.; Chiale, Pablo A.; Molina, Remberto Torres; Ledesman, Raúl; Seapin, Angel O.; Blanco, Manuel Vázquez // Journal of Cardiovascular Pharmacology & Therapeutics;Oct2001, Vol. 6 Issue 4, p341 

    The article assesses the efficacy and safety of amiodarone for restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation in a prospective, randomized, double blind trial. Ninety-five patients with chronic atrial fibrillation, lasting an average of 35.6 months were...

  • Oral Amiodarone for Recent-Onset Atrial Fibrillation. Sadovsky, Richard // American Family Physician;8/15/2000, Vol. 62 Issue 4, p869 

    Presents information on a study by K. Peuhkurinen and others that evaluated the efficacy of a single oral dose of amiodarone versus placebo in patients with recent-onset atrial fibrillation. Description of the study and its results; Conclusion that 30 to 50 mg per kg of oral amiodarone is...

  • I.V. therapy can reduce heart surgery risks. Tarlach, Gemma M. // Drug Topics;5/4/98, Vol. 142 Issue 9, p32 

    Reports that according to a study, the antiarrhythmic drug amiodarone is said to reduce the risk of atrial fibrillation after open heart surgery. Findings of the study by researchers at the Heart Institute of St. Joseph Medical Center in Maryland; Details on the methods used in the Amiodarone...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics